Keyphrases
Lymphocytic Choriomeningitis Virus
92%
Virus
38%
Small Interfering RNA (siRNA)
33%
Human Immunodeficiency Virus Type 1 (HIV-1)
27%
Simian Immunodeficiency Virus
27%
T Cells
24%
Glycoprotein
23%
Lymphocytic Choriomeningitis Virus Infection
22%
Viral
22%
Human T-cell Leukemia Virus Type 1 (HTLV-1)
22%
L-RNA
21%
Persistent Infection
21%
Nucleoprotein
20%
Lymphoid Tissue
19%
Acute Infection
18%
Epithelium
16%
Rhesus Macaque
15%
Virion
15%
HIV Transmission
15%
Arenavirus
15%
Pregenomic RNA (pgRNA)
15%
Mucosal Surfaces
14%
Immune Response
14%
Gene Expression
14%
Infected Cells
13%
Infected Mice
13%
Epithelial Cells
13%
Lymphocytes
12%
Latently Infected
12%
Virus Infection
12%
Cytotoxic T Lymphocytes
12%
Molecular Characterization
12%
In Situ Hybridization
11%
Antiretroviral Therapy
10%
Viral Genome
10%
In Situ
10%
Central Nervous System
10%
Virus Entry
9%
Cell Response
9%
Virus Transmission
9%
Reassortant
9%
HTLV-I Infection
9%
Cervical Epithelium
9%
Persistent Virus Infection
9%
Natural Killer Cells
9%
Viral Gene
8%
High Dose
8%
Vaginal Exposure
8%
Tissue Fibrosis
8%
Primary Infection
8%
Immunology and Microbiology
Lymphocytic Choriomeningitis Virus
100%
Mouse
51%
Viral Disease
38%
Human Immunodeficiency Virus 1
36%
Simian Immunodeficiency Virus
36%
T Cell
34%
Glycoprotein
28%
Lymphoid Tissue
27%
Nucleoprotein
25%
Vaccine Efficacy
25%
Human Immunodeficiency Virus
25%
Surface Property
19%
Arenaviridae
18%
T-Helper Cell
17%
Cytotoxic T Cell
16%
Rhesus Monkey
15%
Virion
14%
Lymphocyte
13%
Reassortment
13%
Immune Response
12%
Cytotoxic T-Cell
12%
Human T Cell Leukemia Virus
12%
Virus Genome
11%
Transgenic Mouse
10%
Target Cell
10%
Amino Acid Sequence
10%
Organ Culture
10%
in Situ Hybridization
10%
Viral Entry
9%
Monospecific Antibody
9%
Human T-Lymphotropic Virus 1
9%
Natural Killer Cell
9%
Virus Infectivity
8%
Gene Expression
8%
Immune Complex
8%
Candida Albicans
8%
Simian Immunodeficiency Virus Vaccine
8%
RNA-dependent RNA Polymerase
8%
Guinea Pig
8%
Infectious Agent
7%
Tissue Culture Cell
7%
Sequence Analysis
7%
Drug Megadose
7%
Human Immunodeficiency Virus Infection
7%
Cell Population
7%
Streptococcus Group A
7%
Viral Protein
7%
Virus Transmission
6%
Viral Genetics
6%
Central Nervous System
6%
Medicine and Dentistry
Infection
25%
Human Immunodeficiency Virus
25%
Lymphocytic Choriomeningitis Virus
24%
T Cell
21%
Virus Infection
14%
Lymphatic Tissue
14%
Antiretroviral Therapy
10%
Ex Vivo
9%
Epithelial Cell
9%
Virion
8%
in Situ Hybridization
8%
Mucosal Surface
7%
Organ Culture
7%
Human T-Lymphotropic Virus 1
7%
Human Immunodeficiency Virus Infection
7%
Disease
6%
Human T Cell Leukemia Virus
6%
Human Immunodeficiency Virus 1 Infection
6%
Gene Expression
6%
Anatomy
6%
Nucleic Acid
6%
Arenavirus
6%
Cytotoxic T-Cell
5%
Central Nervous System
5%
Cell Population
5%
Palatine Tonsil
5%
Lymphocyte
5%
Pancreatic Islet
5%
